Cargando…

Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes

SIMPLE SUMMARY: Hemorrhagic septicemia (HS) and mastitis are important diseases of South Asian dairy animals. Seventy S. aureus/Str. agalactiae-free lactating buffaloes (n = 45) and cows (n = 25) and fifty S. aureus/Str. agalactiae-positive lactating (early stage of lactation) buffaloes (n = 25) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qudratullah, Muhammad, Ghulam, Jamil, Tariq, Rashid, Imaad, Ullah, Qudrat, Saqib, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944738/
https://www.ncbi.nlm.nih.gov/pubmed/35327103
http://dx.doi.org/10.3390/ani12060706
_version_ 1784673792328466432
author Qudratullah,
Muhammad, Ghulam
Jamil, Tariq
Rashid, Imaad
Ullah, Qudrat
Saqib, Muhammad
author_facet Qudratullah,
Muhammad, Ghulam
Jamil, Tariq
Rashid, Imaad
Ullah, Qudrat
Saqib, Muhammad
author_sort Qudratullah,
collection PubMed
description SIMPLE SUMMARY: Hemorrhagic septicemia (HS) and mastitis are important diseases of South Asian dairy animals. Seventy S. aureus/Str. agalactiae-free lactating buffaloes (n = 45) and cows (n = 25) and fifty S. aureus/Str. agalactiae-positive lactating (early stage of lactation) buffaloes (n = 25) and cows (n = 25) were subjected to two doses of Montanide(®) adjuvant combined HS–mastitis vaccine with 21 days of interval. Vaccinated groups showed mean somatic cell counts and mastitis severity scores that were significantly lower (p < 0.05), whereas the milk yield was significantly higher (p < 0.05). In conclusion, this vaccine can be used as a potential preventive measure against HS and mastitis in dairy animals. ABSTRACT: Hemorrhagic septicemia (HS) and mastitis caused by Pasteurella (P.) multocida, Staphylococcus (S.) aureus and Streptococcus (Str.) agalactiae are important ailments of the dairy industry especially in South Asia. The present study evaluates the efficacy of a locally prepared hemorrhagic septicemia (HS) and mastitis combined vaccine. To this end, a total of 70 HS, S. aureus and Str. agalactiae-free lactating (early stage of lactation) buffaloes (n = 45) and cows (n = 25), and 50 lactating (early stage of lactation) cows (n = 25) and buffaloes (n = 25) positive for S. aureus/Str. agalactiae were subjected to two doses of HS–mastitis combined vaccine with an interval of 21 days. Antibody response was monitored by ELISA up to six months (180 days). Antibody titers against HS and mastitis were significantly (p ˂ 0.05) higher in vaccinated groups as compared to the non-vaccinated groups. Cumulative mean somatic cell counts and mastitis severity scores in vaccinated groups were significantly lower (p < 0.05), and milk yield was significantly higher (p < 0.05) than those in the respective non-vaccinated controls. In conclusion, Montanide(®)-adjuvanted HS–mastitis combined vaccine showed significant immunogenic effects in dairy cows and buffaloes. However, challenge studies remain overdue.
format Online
Article
Text
id pubmed-8944738
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89447382022-03-25 Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes Qudratullah, Muhammad, Ghulam Jamil, Tariq Rashid, Imaad Ullah, Qudrat Saqib, Muhammad Animals (Basel) Article SIMPLE SUMMARY: Hemorrhagic septicemia (HS) and mastitis are important diseases of South Asian dairy animals. Seventy S. aureus/Str. agalactiae-free lactating buffaloes (n = 45) and cows (n = 25) and fifty S. aureus/Str. agalactiae-positive lactating (early stage of lactation) buffaloes (n = 25) and cows (n = 25) were subjected to two doses of Montanide(®) adjuvant combined HS–mastitis vaccine with 21 days of interval. Vaccinated groups showed mean somatic cell counts and mastitis severity scores that were significantly lower (p < 0.05), whereas the milk yield was significantly higher (p < 0.05). In conclusion, this vaccine can be used as a potential preventive measure against HS and mastitis in dairy animals. ABSTRACT: Hemorrhagic septicemia (HS) and mastitis caused by Pasteurella (P.) multocida, Staphylococcus (S.) aureus and Streptococcus (Str.) agalactiae are important ailments of the dairy industry especially in South Asia. The present study evaluates the efficacy of a locally prepared hemorrhagic septicemia (HS) and mastitis combined vaccine. To this end, a total of 70 HS, S. aureus and Str. agalactiae-free lactating (early stage of lactation) buffaloes (n = 45) and cows (n = 25), and 50 lactating (early stage of lactation) cows (n = 25) and buffaloes (n = 25) positive for S. aureus/Str. agalactiae were subjected to two doses of HS–mastitis combined vaccine with an interval of 21 days. Antibody response was monitored by ELISA up to six months (180 days). Antibody titers against HS and mastitis were significantly (p ˂ 0.05) higher in vaccinated groups as compared to the non-vaccinated groups. Cumulative mean somatic cell counts and mastitis severity scores in vaccinated groups were significantly lower (p < 0.05), and milk yield was significantly higher (p < 0.05) than those in the respective non-vaccinated controls. In conclusion, Montanide(®)-adjuvanted HS–mastitis combined vaccine showed significant immunogenic effects in dairy cows and buffaloes. However, challenge studies remain overdue. MDPI 2022-03-11 /pmc/articles/PMC8944738/ /pubmed/35327103 http://dx.doi.org/10.3390/ani12060706 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Qudratullah,
Muhammad, Ghulam
Jamil, Tariq
Rashid, Imaad
Ullah, Qudrat
Saqib, Muhammad
Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title_full Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title_fullStr Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title_full_unstemmed Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title_short Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes
title_sort efficacy evaluation of a combined hemorrhagic septicemia–mastitis vaccine in dairy cows and buffaloes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944738/
https://www.ncbi.nlm.nih.gov/pubmed/35327103
http://dx.doi.org/10.3390/ani12060706
work_keys_str_mv AT qudratullah efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes
AT muhammadghulam efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes
AT jamiltariq efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes
AT rashidimaad efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes
AT ullahqudrat efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes
AT saqibmuhammad efficacyevaluationofacombinedhemorrhagicsepticemiamastitisvaccineindairycowsandbuffaloes